UNITED THERAPEUTICS Corp 4

Director Christopher Patusky received an annual equity award of 2,380 shares of United Therapeutics common stock on July 22, 2026.

On July 22, 2026, non-employee director Christopher Patusky of United Therapeutics Corporation received an annual equity compensation award in the form of 2,380 shares of common stock, reported as a stock option-related grant, which will fully vest on the earlier of the one-year anniversary of the grant date or the date of the next Annual Meeting of Shareholders, anticipated to be June 25, 2027; following this routine director award, he beneficially owns 2,410 shares of United Therapeutics common stock directly.

Filing Facts

CIK

1082554

Ticker

UTHR

Form

4

Source Type

fda

Accession

0001231427-26-000004

Alert Tier

5